Nanoparticles (NPs)-mediated systemic mRNA delivery to reverse
https://www.sciencedirect.com/science/article/pii/S2211383522004154
WebMar 1, 2023 · 1. Introduction. Since the first approval of monoclonal antibody, i.e., rituximab (Rituxan), for cancer therapy in 1997, antibody-based therapy has achieved great success and is now one of the most important therapeutic modalities to clinically cure cancer patients 1, 2, 3.The fundamental mechanisms of antibody-based cancer therapy include direct …
DA: 33 PA: 23 MOZ Rank: 60